Gene therapy for glaucoma

Current Opinion in Ophthalmology

Volumn 22, Issue 2, 2011, Pages 73-77

  Demetriades, Anna Maria ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

gene therapy; glaucoma; intraocular pressure; neuroprotection; viral and nonviral vectors

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CALDESMON; CILIARY NEUROTROPHIC FACTOR; CYCLOOXYGENASE 2; DEXAMETHASONE; EXOENZYME C3; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INHIBITOR OF APOPTOSIS PROTEIN; LENTIVIRUS VECTOR; PROTEIN BCL XL; SMALL INTERFERING RNA; VIRUS VECTOR; X LINKED INHIBITOR OF APOPTOSIS;

CILIARY BODY; CILIARY BODY EPITHELIUM; DRUG MECHANISM; DRUG TARGETING; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MUELLER CELL; NEUROPROTECTION; NONHUMAN; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; RNA INTERFERENCE; TRABECULAR MESHWORK;

DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LENTIVIRUS;

EID: 79951944317     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32834371d2     Document Type: Review

References (26)

1. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol 2000; 130:429-440.
2. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008; 358:2231-2239. (Pubitemid 351724452)
3. Fan BJ, Wiggs JL. Glaucoma: genes, phenotypes, and new directions for therapy. J Clin Invest 2010; 120:3064-3072.
4. Liu X, Brandt CR, Gabelt BT, et al. Herpes simplex virus mediated gene transfer to primate ocular tissues. Exp Eye Res 1999; 69:385-395. (Pubitemid 29469906)
5. Barraza RA, Rasmussen CA, Lowen N, et al. Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway in nonhuman primates. Hum Gene Ther 2009; 20:191-200.
6. Buie L, Rasmussen CA, Porterfield EC, et al. Self-complementary AAV virus safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys. IOVS 2010; 51:236-247. This study demonstrates effective long-term transgene expression in the trabecular meshwork of rats and monkeys following an intracameral injection of a new-generation self-complementary adeno-associated virus.
7. Pease ME, Zack DJ, Berlincke C, et al. Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. IOVS 2009; 50:2194-2200.
8. Hangai M, Tanihara H, Honda Y, Kaneda Y. Introduction of DNA into the rat and primate trabecular meshwork by fusogenic liposomes. Invest Ophthalmol Vis Sci 1998; 39:509-516. (Pubitemid 28110682)
9. Jimenez A, Mediero A, Loma P, et al. Efficacy of topically administered siRNAs in glaucoma treatment: in vivo results in hypertensive model. IOVS 2009; 50:4054.
10. Ishikawa H, Takano M, Matsumoto N, et al. Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode. Gene Ther 2005; 12:289-298. (Pubitemid 40310131)
11. Budenz DL, Bennett J, Alonso L, Maguire A. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest Ophthalmol Vis Sci 1995; 36:2211-2215.
12. Liu X, Hu Y, Filla MS, et al. The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis 2005; 11:1112-1121. (Pubitemid 41819512)
13. Gabelt BT, Hu Y, Vittitow JL, et al. Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res 2006; 82:935-944.
14. Comes N, Borras T. Functional delivery of synthetic naked siRNA to the human trabecular meshwork in perfused organ cultures. Mol Vis 2007; 13:1363-1374. (Pubitemid 47207739)
15. Yuan C, Zins EJ, Clark AF, Huang AJ. Suppression of keratoepithelium and myocilin by small interfering RNAs (siRNA) in vitro. Mol Vis 2007; 13:2083-2095. (Pubitemid 350081945)
16. Spiga MG, Borras T. Development of gene therapy with a glucocorticoidinducible MMP1 for the treatment of steroid glaucoma. IOVS 2010; 51:3029-3041.
17. Gerometta R, Spiga MG, Borras T, Candia OA. Treatment of sheep steroid-induced ocular hypertension with glucocorticoid-inducible MMP1 gene therapy virus. IOVS 2010; 51:3042-3048. A glucocorticoid-inducible adenoviral vector that expresses recombinant MMP 1 provides a novel approach for the potential treatment of steroid-induced glaucoma.
18. Kee C, Sohn S, Hwang JM. Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo. Invest Ophthalmol Vis Sci 2001; 42:2856-2860. (Pubitemid 33035283)
19. Barraza RA, McLaren JW, Poeschla EM. Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure. Mol Ther 2010; 18:491-501. In this study, cyclooxygenase-2 prostaglandin synthesis and its response pathway are engineered through the use of lentiviral vectors expressing COX-2 and the prostaglandin FP receptor in the trabecular meshwork and nonpigmented ciliary epithelium in cats resulting in reduced intraocular pressure.
20. Malik JM, Shevtova Z, Bahr M, Kugler S. Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL gene transfer. Mol Ther 2005; 11:373-381. (Pubitemid 40277313)
21. McKinnon SJ, Lehman DM, Tahzib NG, et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther 2002; 5:780-787. (Pubitemid 34619071)
22. Renwick J, Narang MA, Coupland SG, et al. XIAP-mediated neuroprotection in retinal ischemia. Gene Ther 2006; 13:339-347. (Pubitemid 43223103)
23. Di Polo A, Aigner LJ, Dunn RJ, et al. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci U S A 1998; 95:3978-3983.
24. Martin KR, Quigley HA, Zack DJ, et al. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in rat glaucoma model. Invest Ophthalmol Vis Sci 2003; 44:4357-4365. (Pubitemid 37186270)
25. Cheng L, Sapieha P, Kittlerova P, et al. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci 2002; 22:3977-3986. (Pubitemid 37465706)
26. Schmeer C, Straten G, Kugler S, et al. Dose-dependent rescue of axotomized rat retinal ganglion cells by adenovirus-mediated expression of glial cell-line derived neurotrophic factor in vivo. Eur J Neurosci 2002; 15:637-643. (Pubitemid 35471932)